MME, WNDM sign major agreement to distribute CellerateRX

Aug 23 2011

Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market. The initial $2M order from MME is the first of what are expected to be recurring orders to supply its merchant customer base, and MME has agreed to prominently feature CellerateRX® within its direct-to-consumer sales channels.

Scott Haire, Chairman & CEO of Wound Management Technologies said, "Our management team has built a public company consisting of innovative medical products.  While a portion of our larger sales have been pushed into the second half of this year, the MME agreement allows the Company to reiterate its minimum $6M 2011 full-year sales projection.  Additionally, the Company expects sales to accelerate into the 2012 fiscal year."

Mr. Haire further commented, "This is just the beginning of the broadening of our sales channels.  As Wound Management's presence grows in the media space, MME should be able to increase product sales through not only television markets but radio as well.  The agreement facilitates the growth of revenues without having the large sales force most companies require to gain market share in the wound care space.  The Company's goal is to have a consistent and predictable flow of sales through a distribution network, and this agreement is a major step in that direction."

According to Deborah Jenkins Hutchinson, President of Wound Management Technologies: "The need for effective wound care treatment has never been greater, as our population ages and type 2 diabetes affects more and more Americans.  In light of these statistics, the Company has positioned CellerateRX® to be a leading wound care product within many different sales channels.  Today's agreement portends a major penetration in the consumer markets for CellerateRX®.  Wound Management looks forward to supplying MME's growing consumer base."